Month: August 2019

FDA approves Nabriva’s antibiotic for pneumonia

The U.S. Food and Drug Administration said on Monday that it had approved Nabriva Therapeutics Plc’s antibiotic Xenleta for treating patients with community-acquired pneumonia....
AKHBAR.ES
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.